Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Filings indexed 1,291 across all filing types
Latest filing 2018-03-27 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
第二届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 18th meeting of the second board of directors of Zhengzhou Antu Biological Engineering Co., Ltd. It includes approvals of various reports such as the 2017 General Manager Work Report, 2017 Board Work Report, 2017 Independent Directors' Report, 2017 Financial Statements, 2018 Financial Budget, and proposals related to the 2017 Annual Report and profit distribution plan. The document also mentions that these items will be submitted to the 2017 Annual General Meeting for approval. The document is a formal announcement of board meeting decisions rather than the full annual report itself. It is also under 5,000 characters and references reports available on the stock exchange website, indicating it is an announcement rather than the report. Therefore, it fits best as a Board/Management Information (MANG) filing, which covers announcements of board decisions and management information.
2018-03-27 Chinese
2017年度募集资金存放和实际使用专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the management and actual use of funds raised by the company in 2017, including specifics on the amount raised, investment projects, cash management, and compliance with regulatory requirements. It references regulatory guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange, and includes auditor and sponsor institution opinions on the use of the raised funds. The document is titled as a "2017年度募集资金存放和实际使用专项报告" which translates to "2017 Annual Report on the Storage and Actual Use of Raised Funds." This type of report is a specialized disclosure related to capital raised by the company and its usage, fitting the category of Capital/Financing Update (CAP). The document is substantive and not merely an announcement or certification, and it focuses on the use of capital raised rather than general financial performance or earnings. Therefore, the appropriate classification is CAP with high confidence.
2018-03-27 Chinese
关于修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is a detailed announcement about the revision of the company's Articles of Association (公司章程). It includes specific amendments to the company's governance rules, board responsibilities, shareholder meeting procedures, and other internal regulations. The document is issued by the company's board and is intended to inform shareholders and the public about these governance changes. There is no financial data, earnings information, or audit content. The focus is on governance structure and internal rules, which aligns with the category of Governance Information (CGR). The document is substantive and not merely an announcement of a report publication, so it is not RPA. Therefore, the appropriate classification is Governance Information (CGR).
2018-03-27 Chinese
投资委员会工作细则
Governance Information Classification · 95% confidence The document is titled '郑州安图生物工程股份有限公司 投资委员会工作细则' which translates to 'Zhengzhou Antu Bioengineering Co., Ltd. Investment Committee Working Rules'. It outlines the rules, responsibilities, and procedures of the company's investment committee. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no legal proceedings, no capital changes, or any other typical financial or regulatory report content. The document is a governance-related internal policy document describing committee structure and operations, which fits the category of Governance Information (CGR). The document length is short (1954 characters), and it is not an announcement but the actual working rules text. Therefore, the best classification is Governance Information (CGR).
2018-03-27 Chinese
独立董事对公司2017年度对外担保事项的独立意见
Regulatory Filings Classification · 95% confidence The document is a statement from independent directors providing their independent opinion on the company's external guarantees for the fiscal year 2017. It references regulatory guidance on independent directors and company bylaws, and concludes that no external guarantees were made that year. The document is short (308 characters) and is a formal opinion or certification rather than a full report or financial statement. It does not contain financial data or detailed analysis, nor is it an announcement of a meeting or voting results. This type of document fits best under Regulatory Filings (RNS) as it is a compliance-related statement by independent directors regarding a specific matter, without constituting a full audit report or annual report.
2018-03-27 Chinese
招商证券关于安图生物2017年度募集资金的存放与使用情况之专项核查报告
Regulatory Filings
2018-03-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.